106 related articles for article (PubMed ID: 1960043)
1. Biochemical basis of the diabetic embryopathy.
Goldman AS; Goto MP
Isr J Med Sci; 1991; 27(8-9):469-77. PubMed ID: 1960043
[TBL] [Abstract][Full Text] [Related]
2. Dietary myo-inositol therapy in hyperglycemia-induced embryopathy.
Khandelwal M; Reece EA; Wu YK; Borenstein M
Teratology; 1998 Feb; 57(2):79-84. PubMed ID: 9562680
[TBL] [Abstract][Full Text] [Related]
3. Signaling pathways and diabetic embryopathy.
Dhanasekaran N; Wu YK; Reece EA
Semin Reprod Endocrinol; 1999; 17(2):167-74. PubMed ID: 10528367
[TBL] [Abstract][Full Text] [Related]
4. Characterization of differential gene expression profiles in diabetic embryopathy using DNA microarray analysis.
Reece EA; Ji I; Wu YK; Zhao Z
Am J Obstet Gynecol; 2006 Oct; 195(4):1075-80. PubMed ID: 17000240
[TBL] [Abstract][Full Text] [Related]
5. Embryotoxic effects of diabetes on pre-implantation embryos.
Ornoy A; Zusman I
Isr J Med Sci; 1991; 27(8-9):487-92. PubMed ID: 1960045
[TBL] [Abstract][Full Text] [Related]
6. Activation of oxidative stress signaling that is implicated in apoptosis with a mouse model of diabetic embryopathy.
Yang P; Zhao Z; Reece EA
Am J Obstet Gynecol; 2008 Jan; 198(1):130.e1-7. PubMed ID: 18166327
[TBL] [Abstract][Full Text] [Related]
7. PPARdelta and its activator PGI2 are reduced in diabetic embryopathy: involvement of PPARdelta activation in lipid metabolic and signalling pathways in rat embryo early organogenesis.
Higa R; González E; Pustovrh MC; White V; Capobianco E; Martínez N; Jawerbaum A
Mol Hum Reprod; 2007 Feb; 13(2):103-10. PubMed ID: 17148578
[TBL] [Abstract][Full Text] [Related]
8. Aberrant patterns of cellular communication in diabetes-induced embryopathy. I. Membrane signalling.
Reece EA; Ma XD; Wu YK; Dhanasekaran D
J Matern Fetal Neonatal Med; 2002 Apr; 11(4):249-53. PubMed ID: 12375679
[TBL] [Abstract][Full Text] [Related]
9. Multifactorial basis of the syndrome of diabetic embryopathy.
Reece EA; Homko CJ; Wu YK
Teratology; 1996 Oct; 54(4):171-82. PubMed ID: 9122886
[TBL] [Abstract][Full Text] [Related]
10. Experimental mechanisms of diabetic embryopathy and strategies for developing therapeutic interventions.
Zhao Z; Reece EA
J Soc Gynecol Investig; 2005 Dec; 12(8):549-57. PubMed ID: 16325743
[TBL] [Abstract][Full Text] [Related]
11. A diabetes-like environment increases malformation rate and diminishes prostaglandin E(2) in rat embryos: reversal by administration of vitamin E and folic acid.
Wentzel P; Eriksson UJ
Birth Defects Res A Clin Mol Teratol; 2005 Jul; 73(7):506-11. PubMed ID: 15959876
[TBL] [Abstract][Full Text] [Related]
12. [Diabetic embryopathy].
Klein HJ; Fischer R
Med Welt; 1968 Nov; 47():2621-6. PubMed ID: 5732837
[No Abstract] [Full Text] [Related]
13. Diabetic embryopathy: studies using a rat embryo culture system and an animal model.
Akazawa S
Congenit Anom (Kyoto); 2005 Sep; 45(3):73-9. PubMed ID: 16131363
[TBL] [Abstract][Full Text] [Related]
14. [Cooperation for the prevention of diabetic embryopathy (Appeal to physicians concerned)].
Lampé L; Karmazsin L
Orv Hetil; 1983 Mar; 124(11):647-8. PubMed ID: 6843988
[No Abstract] [Full Text] [Related]
15. Maternal diabetes in vivo and high glucose concentration in vitro increases apoptosis in rat embryos.
Gäreskog M; Cederberg J; Eriksson UJ; Wentzel P
Reprod Toxicol; 2007 Jan; 23(1):63-74. PubMed ID: 17034987
[TBL] [Abstract][Full Text] [Related]
16. Altered developmental sequences in diabetic embryopathy.
Wilson GN
N Engl J Med; 1985 Jun; 312(23):1519-20. PubMed ID: 3990756
[No Abstract] [Full Text] [Related]
17. Progressive and selective changes in neurotrophic factor expression and substance p axonal transport induced by perinatal diabetes: protective action of antioxidant treatment.
Germani E; Lesma E; Di Giulio AM; Gorio A
J Neurosci Res; 1999 Aug; 57(4):521-8. PubMed ID: 10440901
[TBL] [Abstract][Full Text] [Related]
18. Diabetes in pregnancy: experimental aspects.
Giavini E
Ann Ist Super Sanita; 1993; 29(1):27-34. PubMed ID: 8129268
[TBL] [Abstract][Full Text] [Related]
19. [Caudal hypoplasia syndrome in diabetic embryopathy].
John K; Hässler A; Hobert I; Friedrich H
Kinderarztl Prax; 1983 Aug; 51(8):377-80. PubMed ID: 6632540
[No Abstract] [Full Text] [Related]
20. Transgenic mice overproducing human thioredoxin-1, an antioxidative and anti-apoptotic protein, prevents diabetic embryopathy.
Kamimoto Y; Sugiyama T; Kihira T; Zhang L; Murabayashi N; Umekawa T; Nagao K; Ma N; Toyoda N; Yodoi J; Sagawa N
Diabetologia; 2010 Sep; 53(9):2046-55. PubMed ID: 20512310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
